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Abstract 
Different genes are expressed in different tissues, depending on functional objectives and selec-
tion pressures. Based on complete knowledge of the structure of the metabolic network and all the 
reactions taking place in the cell, elementary modes (EMs) and minimal cut sets (MCSs) can relate 
compounds observed in a tissue, to the genes being expressed by respectively providing the full 
set of non-decomposable routes of reactions and compounds that lead to the synthesis of external 
products, and the full set of possible target genes for blocking the synthesis of external products. 
So, for a particular tissue, only the EMs containing the reactions that are related to the genes being 
expressed in those tissues, are active for the production of the corresponding compounds. This 
concept is used to develop an algorithm for determining a matrix of reactions (which can be re-
lated to corresponding genes) taking place in a tissue, using experimental observations of com-
pounds in a tissue. The program is applied to the Arabidopsis flower and identified 20 core reac-
tions occurring in all the viable EMs. They originate from the trans-cinnamate compound and lead 
to the formation of kaempferol and quercetin compounds and their derivatives, as well as antho-
cyanin compounds. Analyses of the patterns in the matrix identify reaction sets related to certain 
functions such as the formation of derivatives of the two anthocyanin compounds present, as well 
as the reactions leading from the network’s external substrate erythrose-4P to L-Phenyla- lanine, 
cinnamyl-alc to trans-cinnamate and so on. The program can be used to successfully determine 
genes taking place in a tissue, and the patterns in the resulting matrix can be analysed to deter-
mine gene sets and the state of the tissue. 
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1. Introduction 
The metabolic pathway analysis concepts of elementary modes (EMs) and minimal cut sets (MCSs) represent 
the core concepts used in developing the method presented here. EMs are unique routes, or non-decomposable 
pathways, which consist of the minimal sets of reactions that allow the network to operate at steady state. Fur-
ther information about EMs can be found in [1] [2]. Minimal cut sets are complementary to EMs, and consist of 
the minimal sets of reactions that, when blocked, will repress a certain metabolic functionality by preventing the 
network from achieving steady state. A review of MCSs can be found in [3]. 
Although the metabolic network contains all gene-related reactions and metabolites for that organism, in real 
life only certain genes or enzymes are expressed in certain tissues. So, for a particular tissue, only the EMs con-
taining the reactions that are related to the genes being expressed in those tissues, are active to produce the cor-
responding compounds. Consequently, different compound products are found in different tissues, depending on 
which genes are being expressed. In real life situations, different genes or enzymes are expressed in different 
tissues so certain compounds will be found in certain tissues but not others. Each compound product, however, 
would have the same EMs [4] and MCSs [5]. It is just a matter of determining which of these are activated for a 
certain cell in relation to the genes or enzymes that are expressed or suppressed. 
Based on this idea, we can use experimental results of compounds that are found in a particular tissue, or are 
conversely absent, to identify the viable EMs [4] [6] [7] and MCSs [3] [5] [8] for certain tissues and, subse-
quently, genes that are being expressed in terms of the reactions that are taking place. This will be cheaper and 
easier to use than practical experimental methods such as microarrays which need advanced experimental tech-
nology to carry out and are hard to repeat. 
The metabolic network of an organism is constructed from knowledge and information about the full genome 
of the organism whereby the metabolites and reactions are identified according to their corresponding genes and 
enzymes. Information on genes is available online at resources such as the Kyoto Encyclopaedia of Genes and 
Genomes (KEGG) and The Arabidopsis Information Resource (TAIR) [9].  
Knowledge about when and where a gene is expressed in a cell often provides an idea of its biological role. 
To get a better understanding of the possible functions of genes, DNA microarrays [10] have traditionally been 
used to measure the expression levels of large numbers of genes simultaneously or to study and determine the 
roles of genes [11]-[13]. The DNA microarrays can contain virtually all the genes in a microorganism, and thus 
have been used to study gene expression on a very large scale.  
The pattern of genes expressed can provide information on the state of the cell, a fact that has shifted interest 
towards the study of gene sets from microarrays instead of individual genes, as it is a formidable task defining 
the role of each gene in the full genome of an organism; it is easier to biologically interpret a microarray ex-
periment if differentially expressed genes show similarity in their functional description or occur together in a 
metabolic pathway to form gene sets.  
A gene set is a group of functionally related genes, usually identified from a priori biological knowledge, for 
example, genes that are defined by functional categories or that occur in a known biological pathway.  
New methods for studying gene sets have been developed, for example, [14] presents a method specifically 
designed for defining gene sets using pathways and taking into account the interrelationship of genes in terms of 
the topology of pathways. MCSs could similarly define gene sets but instead of genes, take into account the in-
terrelationship of metabolites and reactions in the metabolic network, so would correspond to gene sets where 
each reaction was uniquely associated with a gene. A review of the analysis methods for gene sets can be seen in 
[15] [16]. 
2. Methods and Approach 
MatLab was used to develop the programmes (not included here) for determining gene expression as described in 
the methods below: 
For a certain tissue at a certain metabolic state, there are sets of “present” and “absent” metabolite products. 
Each product contains ≥ 1 EM and MCS which are complementary to each other.  
The EMs are calculated in relation to compounds present in the tissue:  
• EMs: E1, E2, ···, EM; different M for each product p. 
Each EM forms a route consisting of a non-reducible set of reactions that lead to the formation of the compound 
so, in effect, form a candidate expression vector for the compound present in the tissue. 
S. T. Clark, W. S. Verwoerd 
 
 480 
MCSs are calculated in relation to compounds absent from the tissue: 
• MCSs: C1, C2, ···, CQ; Q = q(em); m = 1, 2, ···, M; different Q for each em. 
Each MCS represents the minimum set of reactions that would be blocked in the tissue, based on the absent 
compound. 
2.1. Binary Matrices for EMs and MCSs 
Consider a binary matrix to represent these EMs and MCSs: 
2.1.1. Binary Matrix of EMs 
• A matrix indicating whether a reaction occurs or does not occur in EMs of products present in a tissue of in-
terest:  
○ a one (1) represents the presence, and  
○ a zero (0) the absence, of a reaction in the corresponding EM responsible for the formation of p in a tissue:  
1 ..
1
( ) , ; ( );  
:
R RN
E
EM p MxN M p
EM
 
=  
 
  
                          (1) 
• where N is the number of reactions in the tissue- the same for all EMs;  
• while M is the number (can differ for different products) of EMs for product p-; and 
• 
1: reaction j occurs in EMi
0: reaction j is not in EMiij
p = 

.  
2.1.2. Binary Matrix of MCSs 
• A matrix indicating whether a reaction does or does not constitute MCSs related to the absence of product p 
from the same tissue:  
○ a one (1) in a MCS row indicates that the corresponding reaction needs to be simultaneously blocked with 
other ones in that MCS row, to suppress p, in order for p to be absent from the tissue;  
○ a zero (0) indicates the reaction does not need to be blocked for that MCS to suppress the formation of 
product p. 
( )( ) ( )
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• Where N is the number of reactions in the tissue- the same for all EMs;  
• Q is the number of MCSs for a particular EM, m, one of the EMs responsible for the formation (objective 
function) of p; and 
• ( )
1: reaction  constitutes cut set 
 
0: reaction  is not in cut set ij
j i
q m
j i

= 

. 
For a compound to be present in a particular tissue, at least one of the EMs responsible for producing that 
compound has to be active which means that the corresponding reactions/genes for that/those EM(s) would be 
expressed in that tissue. If products A and B are present in a tissue, it means that at least one mode of product A 
and one of B must be active. 
For a compound to be absent, all MCSs need to be activated to block all EMs, such that the corresponding 
genes would not be expressed.  
Based on the above idea, we could use experimental results of compounds that are found in a particular tissue 
and vice versa, to identify the viable EMs and MCSs and, subsequently, the genes expressed in that tissue in 
terms of their corresponding reactions. 
The idea is to use both the EMs of compound products present in the tissue and the MCSs of compounds ab-
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sent, to determine the reactions/genes for the Expression matrix X.  
2.2. Compiling the Expression Matrix 
The EMs of all the compounds present in the tissue of interest can be combined to form a matrix of combined 
EMs (cEMs) which is then reduced back to binary. Each column of this matrix would constitute EMs guaranteed 
to produce all the products present in the tissue.  
1
1
1 .. 1 .. 1 ..
1 1 1
, ( )
: : :
i
p pi
R RN R RN R RN
E E E
cE m xN
EM EM EX
     
= + + = ∏     
     
          

              (3) 
• where p is a metabolite product present in the tissue; and  
• X is the product of the number of EMs for all the present products ( mi1∏ ). 
For example, let’s say there are: 
• three metabolites {A, B, C} present in a tissue; and 
• two absent metabolites {D, E}. 
Consider the three metabolite products A, B & C present in the tissue; product A has 3 EMs, product B has 2 
EMs and C has 2 EMs. A cEM that would produce all three metabolites could be obtained by adding together an 
EM from each product set (note that these may overlap) as illustrated in Figure 1. 
The resulting number of cEMs would be 3 × 2 × 2 = 12, so there would be 12 cEMs in the binary matrix where 
each row vector represents a cEM guaranteed to produce the three compounds A, B & C. 
However, it is important to note that some of these cEMs would not actually be viable because their calculation 
does not take into account the “absent” compounds so some might actually be responsible for forming compounds 
that are absent in the tissue! This is also true for EMs responsible for a single compound. 
In this respect, MCSs can be employed to identify viable cEMs and EMs because the reactions constituting a 
cEM or EM cannot be present in the tissue if they also constitute a MCS.  
2.3. Use of MCSs to Verify Elementary Modes 
For each “absent” compound, a MCS could be determined which contains the minimal sets of reactions to sup-
press in order to prevent the production of that compound. The cEMs can then be verified by multiplying its 
transpose by the MCSs of each absent compound: 
( )( ) ( )
1 .. 1 .. 1 ..
1 1 1
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             (4) 
The elements of the product matrix (V) indicate the compatibility of the EMs with the MCSs: 
• A “0” indicates that the MCS is compatible with the EM, i.e., the reactions taking place to produce the present 
compound are not the reactions being blocked to eliminate the absent compound. This means that the cEM is a 
valid Expression vector; 
• A “1” or “non-zero” (if V is not reduced to a binary matrix) in the column indicates that the cEM is not com-
patible with the MCS because the reactions producing the present compounds also need to be blocked to 
eliminate the absent compound. 
Whether the above process is practical will depend on how many EMs there are associated with each product, 
with the total number of combinations: multiplying all the counts could become astronomical.  
2.3.1. An Example Network 
To clarify and check the above processes more, we will apply them to an example network (Figure 2), that has 6 
metabolites and 8 reactions:  
R1: A = B; R2: B = D; R3: A = C; R4: D = C; R5: D; R6: D = E; R7: A + D = F; R8: B + D = F 
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Figure 1. Combining EMs of three compound products.                     
 
 
Figure 2. Example network, ExNet, used in developing the algorithm.          
 
ExNet has 3 external products: C, E & F. 
EMs can be calculated for the three products that guarantee the production of each compound 
Number of EMs calculated = 14: 
• 4 EMs for C: {R5, R4}; {R3}; {R8, R2, R4}; {R1, R2, R4}; 
• 3 EMs for E: {R5, R6}; {R8, R2, R6}; {R1, R2, R6}; 
• 8 EMs for F: {R5, R7}; {R1, R5, R8}; {R2, R4, R8}; {R1, R2, R8}; {R2, R6, R8}; {R8, R2, R7}; {R1, R2, 
R7}; {R2, R5, R8}. 
Now, say that of the 3 compound products, C & E are found in a tissue but not compound F. This indicates that 
the reactions needed to produce compounds C & E are taking place in the tissue so the related genes are being 
expressed, whilst the reactions for compound F are not taking place and the related genes are being suppressed. 
2.3.2. Transpose of cEMs Matrix for Compounds C & E 
The matrix of cEMs for compounds C & E is shown in Table 1. The matrix contains 12 possible combinations of 
EMs (cEMs) that would produce compounds C & E together:  
• For each column vector of the transposed matrix (cEMT): 
o the reactions with a one (1) form the set of reactions in that cEM that would lead to the formation of both 
compounds C & E; 
o A zero (0) indicates the reactions are not involved in that cEM. 
• Each column in the cEMsT is a candidate expression vector X representing an EM (route) containing candidate 
reactions that would guarantee the formation of both compounds C & E. 
2.3.3. MCS matrix of the Absent Compound F 
The absence of compound F indicates that at least one of its MCSs is activated, i.e., the reactions constituting a 
MCS are simultaneously blocked. As illustrated in Table 2, each MCS row in the MCS matrix contains the 
minimal set of reactions that would need to be simultaneously blocked to eliminate the formation of compound F. 
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Table 1. Matrix of cEMs for products C & E.                                                                  
 R1 R2 R3 R4 R6 R7 R5 R8 
cEM1 0 0 0 1 1 0 1 0 
cEM2 0 1 0 1 1 0 1 1 
cEM3 1 1 0 1 1 0 1 0 
cEM4 0 0 1 0 1 0 1 0 
cEM5 0 1 1 0 1 0 0 1 
cEM6 1 1 1 0 1 0 0 0 
cEM7 0 1 0 1 1 0 1 1 
cEM8 0 1 0 1 1 0 0 1 
cEM9 1 1 0 1 1 0 0 1 
cEM10 1 1 0 1 1 0 1 0 
cEM11 1 1 0 1 1 0 0 1 
cEM12 1 1 0 1 1 0 0 0 
 
Table 2. MCSs for compound F where a “1” indicates the reaction is blocked.                                        
 R1 R2 R3 R4 R6 R7 R5 R8 
MCS1 0 1 0 0 1 0 0 0 
MCS2 0 0 0 0 0 0 1 1 
MCS3 1 0 0 0 1 0 0 1 
MCS4 1 1 0 0 0 0 1 0 
MCS5 1 0 0 1 1 1 1 0 
2.3.4. Verifying Combined Elementary Modes 
Multiplying Table 2 (the MCSs in for eliminating compound F) with Table 1 (the transposed matrix of combined 
EMs (cEMsT) responsible for producing C & E), produces a product matrix V that can be used to verify the 
combined modes (cEM) in terms of the compound F being absent in the tissue. The product matrix  
[ ]( ), TF C EV MCS cEM  ×  is shown in Table 3. 
The resulting values in the above product matrix V indicate the following: 
• A zero (0) indicates that the MCS is compatible with the cEM, e.g., for our example network it means that the 
reactions needed to be blocked to eliminate F are not needed for the formation of compound products C & E, 
and vice versa; 
• A non-zero indicates that the cEM clashes with the MCS so the cEM is not viable. 
In this respect, the product matrix V is also the verification matrix and can be interpreted to indicate which cEMs 
are valid in terms of forming compounds C & E without forming compound F.  
A column vector (cEM) containing at least one 0 element in the product matrix V in Table 3, represents a viable 
cEM because there is a MCS for blocking compound F, that does not clash with this particular cEM for forming 
compounds C & E. 
So, for our example network ExNet, the viable expression vectors or cEMs are those containing zeroes in Table 
3: 
• cEM1, cEM3, cEM4, cEM6, cEM10 & cEM12 in relation to MCS2 for which R7 & R8 are blocked;  
• cEMs 1 & 4 in relation to MCS4 for which R1, 2, 7 are blocked. 
The non-viable cEMs are cEM2, cEM5, cEM6, cEM8, cEM9, cEM11 so these can be deleted.  
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Table 3. Product matrix V indicating cEM candidates in relation to MCSs.                                             
 MCS1 MCS2 MCS3 MCS4 MCS5 
cEM1 1 0 1 0 3 
cEM2 2 1 2 1 3 
cEM3 2 0 2 2 4 
cEM4 1 0 1 0 2 
cEM5 1 1 1 1 1 
cEM6 1 0 1 2 2 
cEM7 2 1 2 1 3 
cEM8 1 1 1 1 2 
cEM9 1 1 2 2 3 
cEM10 2 0 2 2 4 
cEM11 1 1 2 2 3 
cEM12 1 0 1 2 3 
 
The resulting expression matrix X would then be as shown in Table 4. 
Using the above approach, an algorithm (not included here) for determining a matrix of reactions (which can 
be related to corresponding genes) taking place in a tissue was developed in MatLab. The algorithm uses expe-
rimental observations of compounds in a tissue and includes verifying EMs for single compounds and eliminat-
ing duplicates and inactive reactions to address the problem posed by combinatorial explosion when combining 
EMs (illustrated in Figure 1). 
3. Application of Algorithm to a “REAL” Example 
The algorithm was applied to floral pigmentation in Arabidopsis using the flavonoid subnetwork reconstructed for 
earlier studies and information from experimental work on identifying flavonoids produced by Arabidopsis 
thaliana wild-type and flavonoid biosynthetic mutant lines [17].  
3.1. Method of Application 
Information from [17] was used in conjunction with the flavonoid subnetwork, FlavNet, used in [18], to compile 
a product binary vector for an Arabidopsis flower, specifying which flavonoids are present and which are not. 
It is important to note that the compounds found present in the Arabidopsis flower from the results of [17], are, 
in effect, cast in stone and definite. However, compounds that are absent are not quite definite because it might 
be that they were just not tested for and/or reported on, and by applying the algorithm, we are assuming that the 
compounds are definitely absent. This case would also apply to any tissue and any other experimental results 
that are used, unless the experiment specifically sets out to check that compounds are actually absent from the 
tissue. 
The CellNetAnalyzer (CNA) program [19] was used to calculate the corresponding EMs needed to produce 
the compounds present in the flower product vector and the MCSs for compounds absent from the product vec-
tor. 
The CNA EMs and MCSs outputs were reformatted and, along with the product vector, form the inputs en-
tered into the algorithm to determine the Expression vector X containing a set of valid EMs for producing all the 
compounds present in the tissue.  
3.2. Results and Discussions  
The product vector compiled for an Arabidopsis flower using FlavNet [18] and information from [17] is 
shown in Table 5 where a one (1) represents the presence, and a zero (0) the absence, of the compound in 
the flower: 
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Table 4. The resulting expression matrix X.                                                                     
 cEM1 cEM3 cEM4 cEM7 cEM10 cEM12 
R1 0 1 0 0 1 1 
R2 0 1 0 1 1 1 
R3 0 0 1 0 0 0 
R4 1 1 0 1 1 1 
R5 1 1 1 1 1 0 
R6 1 1 1 1 1 1 
R7 0 0 0 0 0 0 
R8 0 0 0 1 0 0 
 
Table 5. Product vector for the Arabidopsis flower.                                                               
 flower 
CPD1F-462 1 
CPDQT-26 1 
CPD-5521 1 
CPD-8011 0 
CPD-8012 1 
COUMARYL-ALCOHOL 0 
CPD-1777 0 
CPD-63 0 
PELARGONIDIN-3-GLUCOSIDE-CMPD 1 
CPD1F-766 1 
3.2.1. The Expression Matrix X 
Applying the first 6 steps of the algorithm produces the matrix X containing eligible EMs (columns) with their 
corresponding reactions (rows) as shown in Figure 3.  
As predicted earlier, applying the algorithm to the flavonoid subnetwork produces an Expression matrix X 
containing a large number of eligible EMs such that it is not easy to define the role of each gene and is better to 
analyse X in terms of patterns in the matrix that could be used to determine different gene sets.  
There are 378 eligible EMs and 165 reactions in the Expression matrix X. The reactions are not included in the 
above tables but are kept track of during the manipulation and analysis of matrix X. 
3.2.2. Analysing the Expression Matrix X  
To prepare for analysis, matrix X was cleaned up of reactions that were not needed. The eligible EMs, collectively, 
don’t use a lot of the reactions (yellow cells), as shown in Figure 4, where matrix X is sorted in increasing order of 
the total number of EMs a reaction is involved in.  
The green part corresponds to reactions not participating in any EMs so they can be taken out of the matrix, 
leaving a matrix containing only those reactions that constitute an eligible EM, as shown in Figure 5. 
The matrix in Figure 5 shows that 48 reactions occur in at least one EM of which 20 are ubiquitous reactions 
occurring in all of the eligible EMs (plain yellow part) for the flower tissue. This means that, based on the in-
formation used, these 20 reactions are vital for metabolism in the Arabidopsis flower as they are required for all 
the viable EMs. These core reactions are shown in Table 6. 
The above 20 reactions form the core reactions occurring in all viable EMs of the Arabidopsis flower tissue.  
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Figure 3. Matrix X containing eligible EMs (columns) and their reactions 
(rows).                                                                  
 
 
Figure 4. Sorting by total reactions (rows) in EMs.                            
 
 
Figure 5. Without reactions involved in no EM.                             
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Table 6. The 20 ubiquitous reactions.                                                                         
1 RXN1F-474 CPD1F-90 + DTDP-RHAMNOSE ==> CPD1F-461 + PROTON + TDP 
2 RXN1F-475 CPD1F-461 + DTDP-RHAMNOSE ==> CPD1F-462 + TDP 
3 RXN1F-93 DIHYDROKAEMPFEROL-CMPD + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==> CPD1F-90 + CARBON-DIOXIDE + WATER + SUC 
4 4-COUMARATE-COA-LIGASE-RXN 4-COUMARATE + ATP + CO-A ==> COUMARYL-COA + PPI + AMP 
5 NARINGENIN-3-DIOXYGENASE-RXN NARINGENIN-CMPD + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==> DIHYDROKAEMPFEROL-CMPD + CARBON-DIOXIDE + SUC 
6 LEUCPEL-RXN 
LEUCOPELARGONIDIN-CMPD + OXYGEN-MOLECULE + 
2-KETOGLUTARATE ==> PELARGONIDIN-CMPD + CARBON-DIOXIDE +  
2 WATER + SUC 
7 DIHYDROKAEMPFEROL- 4-REDUCTASE-RXN 
DIHYDROKAEMPFEROL-CMPD + NADPH ==> 
LEUCOPELARGONIDIN-CMPD + NADP 
8 RXN-527 CPD-474 + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==>  CPD-520 + CARBON-DIOXIDE + WATER + SUC 
9 RXNQT-4161 CPD1F-437 + UDP-L-RHAMNOSE ==> CPD-5521 + UDP 
10 RXNQT-4162 CPD-8013 + UDP-L-RHAMNOSE ==> CPDQT-26 + UDP 
11 APIGNAR-RXN APIGENIN ==> NARINGENIN-CMPD + PROTON 
12 RXN-600 CPD-474 + NADPH ==> CPD-590 + NADP 
13 TRANS-CINNAMATE-4- MONOOXYGENASE-RXN 
CPD-674 + OXYGEN-MOLECULE + NADPH ==> 4-COUMARATE + NADP + 
WATER 
14 RXN-602 CPD-590 + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==> CPD-591 + CARBON-DIOXIDE + 2 WATER + SUC 
15 RXN-8266 CPD1F-461 + UDP-GLUCOSE ==> CPD-8012 + UDP 
16 RXN-8267 UDP-L-RHAMNOSE + CPD-520 ==> CPD-8013 + UDP 
17 PELUDP-RXN PELARGONIDIN-CMPD + UDP-GLUCOSE ==> PELARGONIDIN-3-GLUCOSIDE-CMPD + UDP 
18 RXN1F-775 CPD-591 + UDP-GLUCOSE ==> UDP + CPD1F-766 
19 RXN1F-462 CPD-520 + UDP-GLUCOSE ==> CPD1F-437 + UDP 
20 NARINGENIN-CHALCONE- SYNTHASE-RXN 
COUMARYL-COA + 3 MALONYL-COA ==> APIGENIN + 4 CO-A + 3 
CARBON-DIOXIDE 
 
Looking at their position in the network, the reactions originate from the external trans-cinnamate substrate (refer 
to Figure 1 and Figure 3 of [18]) and lead to the formation of kaempferol and quercetin compounds and their 
derivatives as well as anthocyanin compounds although not the anthocyanin derivatives. 
If the yellow part containing the 20 reactions in the above Table 6 is taken out, the remaining matrix is as shown 
in Figure 6 with the reactions on the vertical axis and the viable EMs on the horizontal axis.  
A yellow area in Figure 6 indicates a reaction is involved in the corresponding viable EM while a green one 
means the reaction is not involved in the corresponding EM. The 28 reactions illustrated in the matrix are shown in 
Table 7. 
These 28 reactions occur in some EMs but not others. The different patterns this creates in the matrix could be 
analysed for any relationship it could have to gene sets or information about the corresponding reactions and 
their related genes as well as the EMs and whether different patterns in the EMs could be related to certain func-
tions or the state of the cell. 
Grouping the reactions in Table 7 according to the different patterns discernible by eye in Figure 6, is provided 
in Table 8. 
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Figure 6. The cleaned Expression matrix X: Reactions (y-axis) by viable EMs 
(x-axis).                                                           
3.2.3. Analysis of Grouped Reactions 
The resulting groups in Table 8 show that reactions sharing the same pattern actually share a related function, so 
their corresponding genes would form gene sets related to a certain function e.g., those corresponding to Group 1 
would form the set of genes related to the formation of derivatives of the anthocyanin cyanidin-3-0-glucoside.  
Some reactions do not quite fit into their group (in relation to Figure 6), either because their patterns are a bit 
different or they are not involved in a relatively similar number of EMs, e.g., Reaction 27 from Group 1 and 
Reaction 28 from Group 7 which would fit in with Group 4. These reactions and their corresponding genes could 
be studied further to see if they are actually different in some way. 
3.2.4. Analysis of Grouped EMs 
Looking at vertical patterns in Figure 6 related to EMs, there are four obvious patterns which could be used to 
group the EMs: 
Group 1: [EM1 - EM54], Group 2: [EM55 - EM162], Group 3: [EM163 - EM270] and Group 4: [EM271 - 
EM378]. 
The most obvious difference in these groups is in whether the reactions leading from Erythrose-4P to L- 
Phenylalanine are used (Grp 2 & 4) or not (Grp 1 & 3) but the four groups of EMs could be analysed in detail, e.g., 
to see which reactions are involved and what products they form, to determine if there is a relationship between 
them, such as what kind of metabolite products are being synthesised and through which EMs? This could provide 
an idea of the state of the Arabidopsis flower and the biological processes in the tissue. This would involve ex-
tensive analysis of the 378 EMs which could form a basis for future work. 
3.2.5. Next Steps 
To obtain further and improved information from the Expression matrix the next steps to pursue include: 
• Making use of tools, such as clustering methods, that could further analyse the Expression matrix in detail and 
elucidate gene sets and related biological processes in the tissue; 
• Improving the completeness of experimental information being used. The information used in this study was 
from experimental work that did not specifically look at compounds that were present and absent in the 
Arabidopsis flower, so the fact that a compound was absent could have been just because the study was con-
centrating on other compounds. Having more complete information would improve the accuracy of the results. 
4. Conclusions 
The approach would work best in collaboration with experimental scientists to specifically look at compounds 
present and absent in a tissue of interest. However, the fact that useful information can already be obtained from a 
limited set of data, provides credence for the use and further development of this systems approach method for 
determining and studying gene expression. 
The study shows that the developed algorithm and programmes, work to determine an Expression matrix con-
taining reactions expressed in the tissue, from experimental information about compounds that are present.  
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Table 7. The reactions corresponding to the matrix in Figure 6.                                                      
1 RXN-8169 UDP-GLUCOSE + CPD1F-766 ==> PROTON + UDP + CPD-7138 
2 RXN-8170 COUMARYL-COA + CPD-7138 ==> CO-A + CPD-7714 
3 RXN-8204 COUMARYL-COA + CPD1F-766 ==> CO-A + CPD-7866 
4 RXN-8205 UDP-GLUCOSE + CPD-7866 ==> UDP + CPD-7714 
5 RXN-8176 UDP-GLUCOSE + CPD1F-766 ==> PROTON + UDP + CPD-7842 
27 RXN-8171 MALONYL-COA + CPD-7714 ==> CO-A + CPD-7708 
6 RXN-7828 UDP-GLUCOSE + PELARGONIDIN-3-GLUCOSIDE-CMPD ==> UDP + CPD-7137 
7 RXN-7834 MALONYL-COA + PROTON + PELARGONIDIN-3-GLUCOSIDE-CMPD ==> CO-A + CPD-7149 
8 RXN-8089 CINNAMALDEHYDE + OXYGEN-MOLECULE + WATER ==> CPD-674 + HYDROGEN-PEROXIDE 
12 CINNAMYL-ALCOHOL-DEHYDROGENASE-RXN NADP + CINNAMYL-ALC ==> CINNAMALDEHYDE + NADPH 
9 3-DEHYDROQUINATE-DEHYDRATASE-RXN DEHYDROQUINATE ==> 3-DEHYDRO-SHIKIMATE + WATER 
10 SHIKIMATE-KINASE-RXN SHIKIMATE + ATP ==> SHIKIMATE-5P + ADP 
11 3-DEHYDROQUINATE-SYNTHASE-RXN 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P ==> DEHYDROQUINATE + Pi 
13 PREPHENATE-TRANSAMINE-RXN PREPHENATE + GLT ==> CPD-659 + 2-KETOGLUTARATE 
14 PHEAMINOTRANS-RXN GLT + PHENYL-PYRUVATE ==> PHE + 2-KETOGLUTARATE 
15 2.5.1.19-RXN SHIKIMATE-5P + PHOSPHO-ENOL-PYRUVATE ==> 3-ENOLPYRUVYL-SHIKIMATE-5P + Pi 
16 SHIKIMATE-5-DEHYDROGENASE-RXN 3-DEHYDRO-SHIKIMATE + NADPH ==> SHIKIMATE + NADP 
17 CHORISMATEMUT-RXN CHORISMATE ==> PREPHENATE 
18 CHORISMATE-SYNTHASE-RXN 3-ENOLPYRUVYL-SHIKIMATE-5P ==> Pi + CHORISMATE 
19 CARBOXYCYCLOHEXADIENYL- DEHYDRATASE-RXN CPD-659 ==> PHE + CARBON-DIOXIDE + WATER 
20 DAHPSYN-RXN ERYTHROSE-4P + WATER + PHOSPHO-ENOL-PYRUVATE ==> 3-DEOXY-D-ARABINO-HEPTULOSONATE-7-P + Pi 
21 RXN-5481 CPD-663 + NADPH ==> UDP-L-RHAMNOSE + NADP 
22 RXN-5482 NADPH + UDP-GLUCOSE ==> UDP-L-RHAMNOSE + NADP + WATER 
26 UDP-GLUCOSE-4,6-DEHYDRATASE-RXN UDP-GLUCOSE ==> CPD-663 + WATER 
23 RXN-525 DIHYDROKAEMPFEROL-CMPD + OXYGEN-MOLECULE + NADPH ==> CPD-474 + NADP + WATER 
24 RXN-7652 NARINGENIN-CMPD + OXYGEN-MOLECULE + NADPH ==> CPD-6994 + NADP + WATER 
25 RXN-7775 CPD-6994 + OXYGEN-MOLECULE + 2-KETOGLUTARATE ==> CPD-474 + CARBON-DIOXIDE + SUC 
28 PHENYLALANINE-AMMONIA-LYASE-RXN PHE ==> CPD-674 + PROTON + AMMONIA 
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Table 8. Reaction groups and related functions.                                                                 
Group Reactions Function/Relationship 
1 [1]-[5] [27] Reactions related to the anthocyanin cyanidin-3-0-glucoside and its derivatives 
2 [6] [7] Reactions connecting the anthocyanin pelargonidin-3-glucoside to its 2 derivatives 
3 [8] [12] Reactions linking the external substrate cinnamyl-alc to trans-cinnamate 
4 [9]-[11] [13]-[20] The 11 reactions that lead from the 2 external substrates erythrose-4P  and phenyl-pyruvate to L-phenylalanine (PHE) 
5 [21] [22] [26] Reactions from UDP-glucose to UDP-L-rhamnose 
6 [23]-[25] Reactions connecting Dihydrokaempferol and Naringenin to the production of dihydroquercetin. 
7 [28] The Phenylalanine-ammonia-lyase-rxn linking PHE from Group 4 to trans-cinnamate. 
 
The 20 core reactions that occur in all the viable EMs of the Arabidopsis flower tissue originate from the trans- 
cinnamate compound and lead to the formation of kaempferol and quercetin compounds and their derivatives as 
well as anthocyanin compounds although not the anthocyanin derivatives.  
Analyses of the matrix patterns show that these correspond to reaction sets related to certain functions such as 
the formation of derivatives of the two anthocyanin compounds present, as well as the reactions leading from the 
network’s external substrate erythrose-4P to L-Phenylalanine, cinnamyl-alc to trans-cinnamate and so on. The 
results provide credibility to the program being able to determine reaction sets, from which their corresponding 
gene sets can be established. 
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